PURPOSE OF THESE TERMS Sample Clauses
The "Purpose of These Terms" clause defines the overall intent and scope of the agreement, clarifying what the terms are meant to govern. It typically outlines the relationship between the parties, the subject matter covered, and the context in which the terms apply, such as the use of a website, purchase of goods, or provision of services. By clearly stating the purpose, this clause helps ensure that both parties understand the boundaries and objectives of the agreement, reducing the risk of misunderstandings or disputes about its application.
PURPOSE OF THESE TERMS. The purpose of these Terms is to set the respective rights and obligations of MVO Portugal and the End User with respect to the connection, access to and use of the MVO Portugal National System by the End User in order to verify the authenticity of, and to decommission, the unique identifier of medicinal products in accordance with the provisions of the EU Directive on Falsified Medicines and the Delegated Regulation (the “Purpose”).
PURPOSE OF THESE TERMS. The purpose of this DPA is to identify processing activities of the Data Processor, whilst providing its service (the EGA Service/s) to the Data Controller and the global scientific community, to store submitted dataset(s) of genetic and phenotypic Personal Data with EGA and to distribute these dataset(s) upon DAC decision to various Recipients, requesting access to these data. Acceptance of this DPA implies the commitment to comply with the rights and obligations defined herein and with the requirements established by the legislation on data protection regarding processing of the Personal data defined in Section 3.
PURPOSE OF THESE TERMS. The purpose of these Terms is to identify processing activities of the Data Processor, whilst providing its service to the Data Controller and the global scientific community, to store submitted dataset(s) of genetic and phenotypic Personal Data with EGA and to distribute these dataset(s) upon DAC decision to various Recipients, requesting access to these data. Acceptance of these Terms implies the commitment to comply with the rights and obligations defined herein and with the requirements established by the legislation on data protection regarding processing of the Personal data defined in Section 3.
PURPOSE OF THESE TERMS. 1.1 These global terms of business (the "Terms") and any relevant schedule supplied with these Terms (the "Schedule(s)") will apply to all investment and connected business which may be carried on with or for you by any member of the ▇▇▇▇▇▇▇▇▇ Group.
1.2 These Terms are legally binding and will take effect after receipt by you of the same and/or upon you beginning or continuing to undertake business with us.
1.3 These Terms supersede any previous agreement between us relating to the subject matter of the Terms and any previous version(s) of these Terms.
1.4 All transactions between you and us in "international securities" as that terms is defined in the Rules and Recommendations of the International Capital Markets Association or any successor entity ("ICMA") shall be also subject to the ICMA Rules and Recommendations.
1.5 These Terms shall be supplemented by both country specific and service specific schedules. In the case of conflict between the Terms and any of the accompanying Schedule(s), the terms of the relevant Schedule shall prevail.
PURPOSE OF THESE TERMS. These Terms and Conditions (the “Terms”) set out the rules governing the operation of the TAEX platform (the “Platform”) and define the rights and obligations of users purchasing non-fungible tokens (NFTs) available on the Platform.
PURPOSE OF THESE TERMS. 1.1. The purpose of these Terms is to set out the respective rights and obligations of the NCP and the IT Service Provider with respect to the connection, access to and use of the NCP National System by the IT Service Provider to create and deliver the interface between the User’s system and the NCP NMVS in order to verify the authenticity of, and to decommission, the unique identifier of medicinal products in accordance with the provisions of the EU Directive on Falsified Medicines and the Delegated Regulation (the “Purpose”).
1.2. It is expressly agreed that EMVO and the NMVOs develop and operate the EMVS, including the European Hub and the National Systems, in view of the verification of the authenticity and the decommissioning of the unique identifiers of medicinal products in accordance with the provisions of the EU Directive on Falsified Medicines and the Delegated Regulation, to be operational by 8 February 2019, at 23:59:59 CET at the latest. The EMVS, including the European Hub and National Systems, is therefore still being designed, developed and tested and could therefore be substantially amended, without any indemnity being due to the IT Service Provider.